Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

NCT01148628 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: RAD 001 in combination with Caelyx

Sponsor

Southern Europe New Drug Organization

Collaborators

[object Object]
[object Object]